Table 1.
All | TMb | TFc | P | |
---|---|---|---|---|
Characteristics, N (%) | 696 (100) | 346 (49.7) | 350 (50.3) | |
Age at time of survey (years) | <0.001 | |||
18–29 | 217 (31.2) | 148 (42.8) | 69 (19.7) | |
30–39 | 156 (22.4) | 104 (30.1) | 52 (14.9) | |
40–54 | 168 (24.1) | 69 (19.9) | 99 (28.3) | |
≥55 | 155 (22.3) | 25 (7.2) | 130 (37.1) | |
Race/ethnicity | 0.66 | |||
Non-Hispanic White | 392 (56.3) | 191 (55.2) | 201 (57.4) | |
Non-Hispanic Black | 20 (2.9) | 13 (3.8) | 7 (2.0) | |
Non-Hispanic Asian/Pacific Islander | 48 (6.9) | 25 (7.2) | 23 (6.6) | |
Hispanic | 133 (19.1) | 68 (19.7) | 65 (18.6) | |
Other / Declined | 103 (14.8) | 49 (14.2) | 54 (15.4) | |
History of gender-affirming treatmentsd | <0.001 | |||
None | 28 (4.0) | 11 (3.2) | 17 (4.9) | |
Hormone therapy only | 234 (33.6) | 76 (22.0) | 158 (45.1) | |
Chest surgery without genital surgery | 171 (24.6) | 142 (41.0) | 29 (8.3) | |
Genital surgery with or without chest surgery | 233 (33.5) | 103 (19.8) | 130 (37.2) | |
Missing information | 30 (4.3) | 14 (4.1) | 16 (4.6) | |
Moderate-to-severe acne diagnosis by a physiciane | <0.001 | |||
No | 449 (64.5) | 208 (60.1) | 241 (68.9) | |
Yes - currently | 50 (7.2) | 47 (13.6) | 3 (0.9) | |
Yes - in the past | 95 (13.7) | 50 (14.5) | 45 (12.9) | |
Missing information | 102 (14.7) | 41 (11.9) | 61 (17.4) | |
Ever diagnosis of moderate or severe acne (current or past) | 145 (20.8) | 97 (28.0) | 48 (13.7) | <0.001 |
Moderate or severe acne linked to hormone therapy | <0.001 | |||
No | 76 (53.9) | 33 (34.4) | 43 (95.6) | |
Yes | 65 (46.1) | 63 (65.6) | 2 (4.4) | |
Any visit to a dermatologist | 347 (49.9) | 154 (44.5) | 193 (55.1) | <0.001 |
TM, transmasculine; TF, transfeminine
Numbers may not add up to the total number of participants because, unless otherwise specified, we excluded categories with missing data totaling less than 5%.
Transmasculine refers to transgender persons with current gender identity that differs from female natal sex
Transfeminine refers to transgender persons with current gender identity that differs from male natal sex
Chest surgery referred to any history of mastectomy or breast augmentation, while genital surgery referred to any history of hysterectomy, orchiectomy, vaginectomy, and/or vaginoplasty. The majority (98.3%) of respondents with a history of chest surgery and/or genital surgery has received hormone therapy.
We combined the missing category with no prior history of moderate-to-severe acne to produce conservative estimates of current moderate-to-severe acne prevalence. Acne prevalence may be underestimated in transfeminine persons given higher levels of missing acne data.